2015
DOI: 10.1016/j.molcel.2015.04.031
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Basis of the Rapamycin Insensitivity of Target Of Rapamycin Complex 2

Abstract: Target of Rapamycin (TOR) plays central roles in the regulation of eukaryote growth as the hub of two essential multiprotein complexes: TORC1, which is rapamycin-sensitive, and the lesser characterized TORC2, which is not. TORC2 is a key regulator of lipid biosynthesis and Akt-mediated survival signaling. In spite of its importance, its structure and the molecular basis of its rapamycin insensitivity are unknown. Using crosslinking-mass spectrometry and electron microscopy, we determined the architecture of TO… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
136
0
3

Year Published

2015
2015
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 123 publications
(150 citation statements)
references
References 54 publications
(103 reference statements)
11
136
0
3
Order By: Relevance
“…Low-resolution 3D cryo-EM structures of mTORC1 and TORC2 in yeast have also been reported [21,22]. These structures confirm that both complexes are dimers and show that they form a rhomboid shape with a central cavity.…”
Section: Mtor In Physiology Mtor and Its Complexesmentioning
confidence: 52%
“…Low-resolution 3D cryo-EM structures of mTORC1 and TORC2 in yeast have also been reported [21,22]. These structures confirm that both complexes are dimers and show that they form a rhomboid shape with a central cavity.…”
Section: Mtor In Physiology Mtor and Its Complexesmentioning
confidence: 52%
“…TORC2 contains Tor2, in which the FRB domain exists; however, this TOR complex is not sensitive to rapamycin. This issue was resolved using crosslinking-mass spectrometric and electron microscopic analyses, that is, the C-terminal part of Avo3 was close to the FRB domain, which rendered the Fpr1-rapamycin complex incapable of accessing the FRB domain, resulting in TORC2 insensitivity to rapamycin [25].…”
Section: The Yeast Role In Medical Applicationsmentioning
confidence: 99%
“…The CRIM (conserved region in the middle) domain exists in proximity to the N-terminal side of RBD and has been implicated in binding to the substrates of TORC2 [73,74]. Avo1 binds to the kinase domain of Tor2 via Lst8 [25].…”
Section: Subunit Componentsmentioning
confidence: 99%
See 1 more Smart Citation
“…mTOR consists two multi-protein complexes defined as distinct protein binding partners with Rapamycin (Sirolimus). The first complex is mTORC1, which is known mTOR's rapamycin sensitive complex, and the other one is mTORC2, which is largely insensitive to rapamycin [6] . In studies about the mTOR's effect on the nervous system by using the mTOR inhibitors like rapamycin, it has been shown that mTOR is very important for the development of the central nervous system's cell survival, differentiation, axonal development, synaptogenesis; in adult synaptic plasticity, such as long-term potentiation which plays an important role in the process of learning and memory in hippocampus [7][8][9][10] .…”
Section: Introductionmentioning
confidence: 99%